UAB "Innovative Pharma Baltics" implements a project under the "InoConnect" measure, which aims to promote international networking of companies and involvement in R&D partnership networks. UAB "Innovative Pharma Baltics" is a company operating since 2008, whose main activity is natural products
and production of balanced products from plants.
UAB "Innovative Pharma Baltics" has accumulated many years of operational experience and formed a professional team that helps to ensure the high quality of the activities carried out and compliance with current customer needs. The company is constantly interested in various innovations and innovations and tries to apply them in the company's activities, which helps to ensure the success and efficiency of operations.
During the project, company representatives will go to international R&D events. It is hoped that after the implementation of the project activities, the company will expand its network of international partners, implement joint projects, as well as increase its R&D expenses and submit applications for international R&D initiatives.
The project's funding source is co-financed by the European Union
The value of the project is EUR 39,741.26, the allocated funding is EUR 19,870.63.
The duration of the project implementation is 24 months.
